Biomea Fusion
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biomea Fusion and other ETFs, options, and stocks.About BMEA
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
CEOMichael J. M. Hitchcock
CEOMichael J. M. Hitchcock
Employees106
Employees106
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2017
Founded2017
Employees106
Employees106
BMEA Key Statistics
Market cap106.06M
Market cap106.06M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume3.04M
Average volume3.04M
High today$1.99
High today$1.99
Low today$1.81
Low today$1.81
Open price$1.98
Open price$1.98
Volume4.50M
Volume4.50M
52 Week high$13.07
52 Week high$13.07
52 Week low$1.29
52 Week low$1.29
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own BMEA. This list is generated using Robinhood data, and it’s not a recommendation.